Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Post-exposure and pre-exposure prophylaxis could be a game-changer for immunocompromised people.
Powell had received treatment for multiple myeloma, which can lead to poorer response to COVID-19 vaccines.
Co-occurring health disorders appear to contribute to increased risk, NIH study suggests.
A growing number of transplant programs are barring patients who refuse COVID vaccines or giving them lower priority on waiting lists.
Molnupiravir reduces severe illness and death, but it must be started within days after developing symptoms.
Collins has led the NIH under three presidents over more than 12 years.
A steady stream of spurious claims about COVID-19 vaccines and treatments swirl around the public consciousness.
News and tweets from the SYNChronicity 2021 Conference on HIV, hepatitis C, sexually transmitted infections and LGBTQ health
I’d put my breakthrough case of COVID right up there with my worst bouts of flu.
Recommendation includes people over 65, those with underlying medical conditions and those with occupational risk.
Third dose OK’d for people over 65, those at risk for severe COVID-19 and those at high risk of exposure to the coronavirus.
The committee voted against third shot for all adults, however, casting doubts on Biden’s booster plan.
Full approval could encourage more people to get vaccinated and raises the prospect of off-label use.
The booster is recommended for organ transplant recipients, people receiving cancer treatment and people with advanced or untreated HIV.
Trial will assess antibody response in people who did not respond to two-dose regimen.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.